Comparison · NCT03389555-5ed8d5db
Vitamin C, Vitamin B1, Corticosteroids vs Placebo: Renal Failure
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Vitamin C, Vitamin B1, Corticosteroids vs Placebo: Renal Failure. Trial comparisons, record NCT03389555-5ed8d5db. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03389555-5ed8d5db
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.317 | 0.234 | 0.413 | wilson | |
| Risk in group 2 | 0.273 | 0.195 | 0.368 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0441 | -0.0818 | 0.168 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.16 | 0.755 | 1.79 | log | |
| Odds ratio, group 1 over group 2 | 1.24 | 0.672 | 2.27 | log | |
| Number needed to treat, for one more participant with the outcome on Vitamin C, Vitamin B1, Corticosteroids than on Placebo | 22.7 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Vitamin C, Vitamin B1, Corticosteroids | The combination of vitamin C, vitamin B1, hydrocortisone :~* Vitamin C (ascorbic acid) 1.5g every 6 hours x 4-days~* Vitamin B1 (thiamine) 100mg every 6 hours x 4-days~* Hydrocortisone 50mg every 6 hours x 4-days~vitamin C, vitamin B1, hydrocortisone: Vitamin C (1.5g) plus vitamin B1 (100mg) will be diluted in 100ml 0.9%NACL and administered IV every 6 hours for 4 days or until participant is discharged from the ICU. Hydrocortisone 50mg/ml will be administered via IV push over 1-2 minutes every 6hours for 4 days or until the patient is discharged from the ICU. | 32 | 101 | OG000 |
| Group 2 | Placebo | Normal Saline Solution (0.9%NaCl) in a volume to match all experimental arm components~Normal saline: Normal saline (0.9% NaCl solution) volume to match all components | 27 | 99 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Renal Failure
- Description
Development of renal failure as defined by a Kidney Disease Improving Global Outcomes \[KDIGO\] stage 3 or higher. There are 3 stages in the KDIGO scale with stage 3 being the worst (corresponds to renal failure).~Stage 1- serum creatinine 1.5 to 1.9 times baseline OR an increase in serum creatinine ≥ 0.3 mg/dL OR urine output \< 0.5ml/kg/hour for 6-12 hours. Stage 2- serum creatinine 2.0-2.9 times baseline OR urine output \<0.5mg/kg/hour for ≥ 12 hours Stage 3- serum creatinine 3.0 times baseline (or serum creatinine of more than or equal to 4.0 mg/dl with an acute increase of at least 0.5 mg/dl) (OR) Urine output less than 0.3 ml/kg/hour for 24 hours or anuria for 12 hours or new renal replacement therapy
- Time frame
- Enrollment until 7-days or discharge from the ICU
- Population
Source ClinicalTrials.gov
Trial
- Title
- Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial
- NCT number
- NCT03389555
- Phases
- PHASE2, PHASE3
- Conditions
- Sepsis, Septic Shock, Metabolic Disturbance
- Interventions
- vitamin C, vitamin B1, hydrocortisone, Normal saline
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Results first posted
- 2021-01-29
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03389555?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03389555-5ed8d5db